While a Supreme Court order continues to ensure the drug is still widely available, the issue returned Wednesday to the Fifth Circuit Court of Appeals as lawyers for both sides urged the court to act.

A decision is expected soon in a case challenging the FDA's approval of mifepristone, a drug commonly used to induce abortions.